MG Matt Gline Biotech industry voice who hosts Off-Target Effects with Matt Gline, a BiotechTV interview series with investors and company leaders such as Perceptive's Joe Ed...

“I feel like we're all just strapped to this AI thing. And thank God it's not my job to try and figure out where that's going, because I don't know. But I feel like 2027 is going to be defined first by the answer to the question: is there an AI bubble that bursts spectacularly?”

Biotech Hangout · Health & Longevity · November 2026

“I feel like we're all just strapped to this AI thing. And thank God it's not my job to try and figure out where that's going, because I don't know. But I feel like 2027 is going to be defined first by the answer to the question: is there an AI bubble that bursts spectacularly?” — Matt Gline, Biotech Hangout

Context

The hosts were asked how they see 2027 for biotech, after a co-host argued for a big M&A year. Gline says biotech's fate now hangs on whether the AI trade holds. He said it the day after the Anthropic IPO, during a sharp market pullback.

Transcript

Biotech Hangout Around 03:20 into the episode
Tim Opler

…is going to be a significant M ⁇ A year. We're seeing the rumors out this week, for example, that Sanofi might be doing something on Instemate. Who knows? But that's sort of exemplary of kind of what I was trying to say, which is expect a lot of M ⁇ A and that should carry up the biotech market.

Graig Suvannavejh

…about 2027, especially as we come down to the end of 2026? Do we think that it's going to be as robust of an IPO market and a biotech performance perspective? I could see M ⁇ A at a good pace. In fact, it could even increase given Tim's comments. But anyone else want to comment about 2020-27?

Matt Gline

For me, and you would ask me to make a comment about the Anthropic IPO too. I think the main thing that I find difficult to reason through is there's like a whole bunch of biotech specific dynamics. I thought Tim did a really nice job of laying it out. It feels like we are all strapped to a whatever. We're like the cartoon where like the guy catches a shark by accident on his fishing line and then the shark is like dragging him all over the lake or the ocean. I feel like we're all just like strapped to this AI thing. And it's, you know, thank God it's not my job to try and figure out where that's going because I don't know. But I feel like 2027, if I had to guess, is going to be defined first by the answer to the question, like, is there an AI bubble that bursts spectacularly? In which case, how exactly that affects biotech is difficult to predict, but it's probably not going to be fun. Or like, do we somehow sail through that moment without that, in which case it'll be better? And I feel like the capital markets first and foremost will wind up dominated by…

Brian Skorney

Yeah, let me just add to what Matt's saying, because I think he's spot on. So I did a, I was thinking the same themes and I did a quick AI search. So take it with a grain of salt. But I said, what percent of the total U.S. stock market publicly traded companies is represented by the companies that…

Tim Opler

that. I did not know that statistic. That's interesting.

Brian Skorney

Yeah. So that supports the theme that a lot of this is AI or tech. And man, we're kind of beholden to the market if those companies crater. because they are shifting their business model and they're not the cash machines that Google used to be and just printing money. That's not the case with these…

Speaker names come from our own diarization. The position is estimated from where the line sits in the episode.

More from Biotech Hangout